NEW YORK (GenomeWeb News) — Third Wave Technologies today said it has countersued Digene after the company sued Third Wave in January for allegedly infringing its human papillomavirus IP.
 
In its suit, filed with the US District Court for the Western District of Wisconsin, Third Wave claims Digene has “abused its monopoly power to thwart competition” in the HPV diagnostics market.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.